Krystal Biotech

The Patient Access Liaison provides non-medical educational assistance to patients and healthcare providers regarding product reimbursement, distribution, and insurance processes. They manage the patient journey to ensure adherence to therapy and coordinate access to care sites and affordability options.

The RGTC is responsible for the successful commercial launch of Vyjuvek for the treatment of dystrophic epidermolysis bullosa within the Southwest territory. This involves educating healthcare professionals, driving patient identification, and building consultative relationships with academic and community providers.

The RGTC is responsible for the successful commercial launch and promotion of Vyjuvek to pediatric dermatologists and other key stakeholders within the Southwest territory. This includes driving patient identification, educating healthcare professionals on the therapy, and collaborating with internal teams to ensure medication access.

The role focuses on implementing solutions to improve the patient journey and managing long-term partnerships with stakeholders in the EB ecosystem. Key duties include training healthcare professionals on drug administration and achieving sales goals for B-VECT in North Germany.

The role focuses on improving the patient journey for DEB patients by engaging stakeholders and training healthcare providers on drug administration. It involves achieving sales goals for B-VECT through strategic account planning and building a network of reference centers.